Stock listing

4BMRN Stock Price, News, Filings & Events — Biomarin Pharmaceutical Inc.

Selected listing: 4BMRN · EUROTLX · EUR · IT

The 4BMRN:EUROTLX listing represents Biomarin Pharmaceutical Inc., a company focused on developing innovative biopharmaceuticals for serious diseases and medical conditions. Recently, Biomarin has been in the news for advancements in its gene therapy programs and updates on clinical trial results. The company regularly files reports that provide insights into its research progress and regulatory approvals. Investors can stay informed about upcoming events and market developments that may impact Biomarin's performance in the biopharmaceutical sector.

4BMRN:EUROTLXEURITUpdated July 20, 2026
Biomarin Pharmaceutical Inc. logo
Ticker
4BMRN:EUROTLX
Asset type
Stock
Market cap
$11.40B
Sector
Health Technology
Industry
Biotechnology
Exchange
EUROTLX
Currency
EUR

Biomarin Pharmaceutical Inc. 4BMRN:EUROTLX stock context

The 4BMRN:EUROTLX listing represents Biomarin Pharmaceutical Inc., a company focused on developing innovative biopharmaceuticals for serious diseases and medical conditions. Recently, Biomarin has been in the news for advancements in its gene therapy programs and updates on clinical trial results. The company regularly files reports that provide insights into its research progress and regulatory approvals. Investors can stay informed about upcoming events and market developments that may impact Biomarin's performance in the biopharmaceutical sector.

Research Biomarin Pharmaceutical Inc.

Alternate listings